📰 Dendritic Cell News
Page 3 - Dendritic Cell News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dendritic Cell. Real-time updates on events, politics, business and more.
March 22, 2022
22.03.2022 - DGAP-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE THERAPEUTICS: AN ANTI-CANCER SOLUTIONS PLATFORM COMPANY ADVANCING ITS VERSATILE ACCUM TECHNOLOGY 22.03.2022 / 08:30 The issuer is solely responsible for the content of this ... Seite 1
March 22, 2022
Vancouver, British Columbia--(Newsfile Corp. - March 22, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF)("Defence" or the "Company"), a Canadian biotech company actively working
March 22, 2022
DGAP-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous22.03.2022 / 08:30 The issuer is solely responsible for the content of this announcement.CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASEDEFENCE THERAPEUTICS: AN ANTI-CANCER SOLUTIONS PLATFORM COMPANY ADVANCING ITS VERSATILE ACCUM TECHNOLOGYVancouver, BC,...
March 22, 2022
GMP Unit of The University of Birmingham - for the preparation of its Dendritic Cell vaccine AccuVAC-D001M in accordance with EU GMP. This is the final step for submission to the MHRA in preparation... | March 22, 2022
February 17, 2022
/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...
February 17, 2022
/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...
February 17, 2022
BETHESDA, Md., Feb. 17, 2022 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers
February 17, 2022
BETHESDA, Md., Feb. 17, 2022 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax® persona...
December 31, 2021
New research revealed that vaccine-breakthrough infections might elicit cross-reactive bNAbs against all variants of concern.
December 21, 2021
In this interview, Carol Stonham, the head of a Locality Based FeNO referral service, talks to NewsMed about measuring airway inflammation when diagnosing and treating asthma patients.